Preventing Alzheimers disease-related gray matter atrophy by B-vitamin treatment
In this trial, 748 cognitively healthy elderly adults, aged 70-79 years, were supplemented for two years with a combination of 500 mg/day of DHA and 200 mg/day of eicosapentaenoic acid or with a placebo containing olive oil
24 GLP-1, used for treating diabetes, is quickly broken down in the body, requiring high doses that can cause side effects like nausea
The combination of covalent capture and rapid binding kinetics overcomes the equilibrium-based limitations associated with traditional affinity tags and enables efficient capture even at low expression levels
Another small trial, the Effect of Semaglutide 2.4 mg Once Weekly on Function and Symptoms in Subjects with Obesity-related Heart Failure with Preserved Ejection Fraction (STEP-HFpEF) trial assesed semaglutide efficay in patients with preserved LVEF (LVEF 45%) and obesity (BMI 30 kg/m 2 )